dc.creator | Zarogiannis, S. | en |
dc.creator | Hatzoglou, C. | en |
dc.creator | Gourgoulianis, K. | en |
dc.creator | Molyvdas, P. A. | en |
dc.date.accessioned | 2015-11-23T10:54:47Z | |
dc.date.available | 2015-11-23T10:54:47Z | |
dc.date.issued | 2006 | |
dc.identifier.issn | 1073449X | |
dc.identifier.uri | http://hdl.handle.net/11615/34840 | |
dc.source.uri | http://www.scopus.com/inward/record.url?eid=2-s2.0-33744929899&partnerID=40&md5=61da5fcec312ffd6bc3650a857fb091d | |
dc.subject | beta adrenergic receptor | en |
dc.subject | beta adrenergic receptor stimulating agent | en |
dc.subject | Ringer lactate solution | en |
dc.subject | acute lung injury | en |
dc.subject | adult respiratory distress syndrome | en |
dc.subject | aerosol | en |
dc.subject | clinical trial | en |
dc.subject | drug blood level | en |
dc.subject | drug delivery system | en |
dc.subject | drug efficacy | en |
dc.subject | heart disease | en |
dc.subject | human | en |
dc.subject | in vivo study | en |
dc.subject | letter | en |
dc.subject | lung clearance | en |
dc.subject | lung edema | en |
dc.subject | lung extravascular fluid | en |
dc.subject | membrane permeability | en |
dc.subject | nonhuman | en |
dc.subject | pleura cavity | en |
dc.subject | pleura effusion | en |
dc.subject | priority journal | en |
dc.subject | rabbit | en |
dc.subject | sodium transport | en |
dc.subject | water absorption | en |
dc.subject | Administration, Inhalation | en |
dc.subject | Adrenergic beta-Agonists | en |
dc.subject | Aerosols | en |
dc.subject | Animals | en |
dc.subject | Extravascular Lung Water | en |
dc.subject | Humans | en |
dc.subject | Permeability | en |
dc.subject | Pleural Effusion | en |
dc.subject | Pulmonary Edema | en |
dc.title | Pleural cavity exploitation in β-agonist-treated ARDS patients [3] | en |
dc.type | journalArticle | en |